• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov18
Evercore ISI Analyst Maintains Buy Rating on Edgewise Therapeutics
10:42
Nov14
JP Morgan Raises Target Price, Driving Edgewise Therapeutics Stock Up
17:29
Nov13
Piper Sandler Analyst Maintains Buy Rating for Edgewise Therapeutics
11:52
Nov7
H.C. Wainwright Reiterates Buy Rating on Edgewise Therapeutics
12:02
Nov6
Edgewise Therapeutics released FY2025 Q3 earnings on November 6, Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.39 (forecast USD -0.3932)
14:30
Edgewise Therapeutics released FY2025 9 Months Earnings on November 6 Pre-Market EST, actual revenue USD 0, actual EPS USD -1.1584
14:30

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -40.67 M, EPS -0.3854

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -36.12 M, EPS -0.3441

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -40.8 M, EPS -0.4288

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
11.340
+111.96%
+5.990
PCSA
5.928
+97.25%
+2.923
ATPC
0.1487
+65.22%
+0.059
VYNE
0.6426
+59.57%
+0.240
YCBD
2.240
+56.64%
+0.810
ISPO
4.170
+46.83%
+1.330
MDLN
39.380
+35.79%
+10.380
BENF
5.048
+34.98%
+1.292
GVH
3.955
+34.07%
+1.005
ANDG
21.000
+31.25%
+5.000
View More